A Comparative Multicenter Cohort Study Evaluating the Long-Term Influence of the Strict Lockdown during the First COVID-19 Wave on Lung Cancer Patients (ARTEMISIA Trial).

COVID-19 epidemiology lung neoplasms quality of healthcare real-world

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
06 Dec 2023
Historique:
received: 09 11 2023
revised: 29 11 2023
accepted: 02 12 2023
medline: 23 12 2023
pubmed: 23 12 2023
entrez: 23 12 2023
Statut: epublish

Résumé

The consequences of the strict health restrictions during the first wave of COVID-19 on lung cancer (LC) patients are not known. This cohort study evaluated the impact of the initial lockdown on management of and long-term outcome in LC patients. This exposed-unexposed-type study included two evaluation periods of 6 months each in non-selected patients; one began on the first day of lockdown in 2020, and the other in 2019 during the same calendar period. Various indicators were compared: clinical profiles, management delays and overall survival beyond 2 years. A total of 816 patients from 7 public or private centers were enrolled. The clinical characteristics of the patients in 2020 did not differ from those in 2019, except that the population was older (

Identifiants

pubmed: 38136275
pii: cancers15245729
doi: 10.3390/cancers15245729
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Olivier Molinier (O)

Respiratory Medicine Department, Hospital Center, 194 Avenue Rubillard, CEDEX 9, 72037 Le Mans, France.

Camille Guguen (C)

Respiratory Medicine Department, Hospital Center, 194 Avenue Rubillard, CEDEX 9, 72037 Le Mans, France.

Marie Marcq (M)

Respiratory Medicine Department, Hospital Center, 85925 La Roche-sur-Yon, France.

Anne-Laure Chene (AL)

Respiratory Medicine Department, Thorax Institute, University Hospital Center, University of Nantes, 44093 Nantes, France.

Philippe Masson (P)

Respiratory Medicine Department, Hospital Center, 49300 Cholet, France.

Frédéric Bigot (F)

Oncology Department, Western Cancer Institute Paul Papin, 49105 Angers, France.

Fabrice Denis (F)

Oncology Department, Clinique Victor Hugo, 72000 Le Mans, France.

Fabienne Empereur (F)

Regional Cancer Network ONCOPL, 44093 Nantes, France.

Philippe Saulnier (P)

Biostatistics Department, National Institute of Health and Medical Research, University of Angers, 49100 Angers, France.

Thierry Urban (T)

Respiratory Medicine Department, University Hospital Center, 49100 Angers, France.

Classifications MeSH